Meta-Analysis of Cerebral Embolic Protection Devices During TAVR Procedures

Mohamed Saad Sayed's meta-analysis evaluates the efficacy and safety of cerebral embolic protection devices during transcatheter aortic valve replacement. The study analyzes nine randomized controlled trials comprising 11,696 patients, with results published on figshare in May 2026. It found no significant reduction in stroke risk with device use compared to control groups.

Use Cases

• Evaluating the clinical efficacy of medical devices based on aggregated randomized trial data.
• Conducting secondary analysis of stroke and mortality outcomes in TAVR patients.
• Comparing the performance of filter-based versus deflection-based cerebral protection devices.
• Informing clinical guidelines and device adoption decisions based on meta-analytic evidence.

Strengths

• Analysis is based on 11,696 patients from nine randomized controlled trials, providing a substantial sample.
• Follows PRISMA guidelines for systematic review, suggesting a structured methodology.
• Results are disaggregated by device type (Sentinel and TriGuard), allowing for comparative insight.

Limitations

• Dataset is a 1001.2 KB DOCX document; the underlying structured data is not directly accessible.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for quantitative modeling.

Provenance

Source

figshare

Collection Method

Systematic review and meta-analysis of published randomized controlled trials.

Freshness

Last updated 2026-05-18 09:24:36